Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Front Public Health ; 8: 596168, 2020.
Artículo en Inglés | MEDLINE | ID: covidwho-1055005

RESUMEN

Background: Six months since the outbreak of coronavirus disease (COVID-19), the pandemic continues to grow worldwide, although the outbreak in Wuhan, the worst-hit area, has been controlled. Thus, based on the clinical experience in Wuhan, we hypothesized that there is a relationship between the patient's CO2 levels and prognosis. Methods: COVID-19 patients' information was retrospectively collected from medical records at the Leishenshan Hospital, Wuhan. Logistic and Cox regression analyses were conducted to determine the correlation between decreased CO2 levels and disease severity or mortality risk. The Kaplan-Meier curve analysis was coupled with the log-rank test to understand COVID-19 progression in patients with decreased CO2 levels. Curve fitting was used to confirm the correlation between computed tomography scores and CO2 levels. Results: Cox regression analysis showed that the mortality risk of COVID-19 patients correlated with decreased CO2 levels. The adjusted hazard ratios for decreased CO2 levels in COVID-19 patients were 8.710 [95% confidence interval (CI): 2.773-27.365, P < 0.001], and 4.754 (95% CI: 1.380-16.370, P = 0.013). The adjusted odds ratio was 0.950 (95% CI: 0.431-2.094, P = 0.900). The Kaplan-Meier survival curves demonstrated that patients with decreased CO2 levels had a higher risk of mortality. Conclusions: Decreased CO2 levels increased the mortality risk of COVID-19 patients, which might be caused by hyperventilation during mechanical ventilation. This finding provides important insights for clinical treatment recommendations.


Asunto(s)
COVID-19/sangre , Dióxido de Carbono/sangre , Hiperventilación/diagnóstico , Respiración Artificial/efectos adversos , Anciano , Biomarcadores/sangre , Análisis Químico de la Sangre , Pruebas de Coagulación Sanguínea , COVID-19/mortalidad , COVID-19/terapia , Femenino , Mortalidad Hospitalaria , Humanos , Hiperventilación/etiología , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Neumonía Viral/sangre , Modelos de Riesgos Proporcionales , Estudios Retrospectivos , Factores de Riesgo
2.
Epilepsy Behav ; 115: 107404, 2021 02.
Artículo en Inglés | MEDLINE | ID: covidwho-972215

RESUMEN

The diagnosis of childhood absence epilepsy (CAE) is typically based on history and description of spells, supported by an office-based positive hyperventilation test and confirmed by routine electroencephalography (EEG). In the current coronavirus disease 2019 (COVID-19) pandemic, many pediatric neurologists have switched to telemedicine visits for nonemergent outpatient evaluations. We present a series of children diagnosed as having CAE on the basis of a positive hyperventilation test performed during remote televisits. Several of these children were begun on treatment for CAE prior to obtaining an EEG, with significant seizure reduction. Our series documents the feasibility of CAE diagnosis and management by telemedicine.


Asunto(s)
Anticonvulsivantes/uso terapéutico , COVID-19/prevención & control , Manejo de la Enfermedad , Epilepsia Tipo Ausencia/diagnóstico , Epilepsia Tipo Ausencia/tratamiento farmacológico , Telemedicina/métodos , COVID-19/epidemiología , Niño , Preescolar , Electroencefalografía/métodos , Electroencefalografía/tendencias , Epilepsia Tipo Ausencia/epidemiología , Femenino , Humanos , Hiperventilación/diagnóstico , Hiperventilación/epidemiología , Masculino , Neurólogos/tendencias , Pediatras/tendencias , SARS-CoV-2 , Telemedicina/tendencias , Ácido Valproico/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA